whoa. whoa. whoa.

You're being directed to the ELOCTATE Healthcare Professional website. If you're okay with that, we're okay with that.

Come back soon!

Home Hero

KENNY BLAZES NEW TRAILS

As an avid cyclist with Hemophilia A, Kenny has had his share of uphill struggles.

He counts on the protection* offered by his every-4-day ELOCTATE prophylaxis regimen to keep his body and joints protected from bleeds while he keeps on pedaling.

*ELOCTATE has been proven to help patients prevent bleeding episodes using a prophylaxis regimen.

See Transcript

Q&A

We know you’re passionate about riding, tell us about your other passion: your family?

I was put up for adoption as a newborn. My first adoptive family returned me to the orphanage when I was diagnosed with Hemophilia A. My second adoptive family was more accepting, so I grew up in a supportive, loving home. It's made me appreciate my own wife and kids that much more.

How did you hear about ELOCTATE?

I like to get involved and give back to the hemophilia community. I learned about ELOCTATE through my volunteering. Its extended protection from bleeds and joint bleeds seemed promising.

And how is the switch to ELOCTATE working out?

I worked with my doctor to come up with a prophy infusion schedule of every four days. The protection I'm getting gives me comfort to keep biking, hiking, and keeping active any way I can. This is just my experience.

Any words of wisdom?

I tell my kids: "Don't worry about what you can't control, worry about what you can control."

Note: Patient stories reflect the real-life experiences of persons diagnosed with hemophilia A who have been prescribed ELOCTATE. However, individual experiences may vary. Patient stories are not necessarily representative of what another person using ELOCTATE may experience. Talk to your healthcare provider about what's right for you. ELOCTATE Peers have been compensated for sharing their stories.

The recommended starting regimen is 50 IU/kg every 4 days as directed by your doctor. In children under 6 years of age, the recommended starting regimen is 50 IU/kg administered twice weekly. The regimen can be adjusted based on your body's individual response

IMPORTANT SAFETY INFORMATION AND INDICATIONS

+

IMPORTANT SAFETY INFORMATION

Do not use ELOCTATE if you have had an allergic reaction to it in the past.

Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII.

Allergic reactions may occur with ELOCTATE. Call your healthcare provider or get emergency treatment right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.

Your body can also make antibodies called "inhibitors" against ELOCTATE, which may stop ELOCTATE from working properly.

Additional common side effects of ELOCTATE are headache, rash, joint pain, muscle pain and general discomfort.

If you have risk factors for developing abnormal blood clots in your body, such as an indwelling venous catheter, treatment with Factor VIII may increase this risk.

These are not all the possible side effects of ELOCTATE. Talk to your healthcare provider right away about any side effect that bothers you or that does not go away, or if bleeding is not controlled after using ELOCTATE.

INDICATIONS

ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery.

PLEASE SEE FULL PRESCRIBING INFORMATION

MANUFACTURED BY

Bioverativ Therapeutics Inc.
Waltham, MA 02451 USA
U.S. License #2078

CLICK HERE TO LEARN MORE ABOUT SANOFI'S COMMITMENT TO FIGHTING COUNTERFEIT DRUGS.